X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3359) 3359
Newsletter (55) 55
Magazine Article (12) 12
Book Chapter (10) 10
Dissertation (4) 4
Publication (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2644) 2644
science & technology (2324) 2324
life sciences & biomedicine (2276) 2276
male (1825) 1825
female (1724) 1724
clarithromycin - administration & dosage (1598) 1598
clarithromycin (1448) 1448
middle aged (1265) 1265
adult (1255) 1255
helicobacter infections - drug therapy (1210) 1210
anti-bacterial agents - administration & dosage (1146) 1146
clarithromycin - therapeutic use (1120) 1120
drug therapy, combination (1098) 1098
helicobacter pylori (975) 975
anti-bacterial agents - therapeutic use (973) 973
aged (881) 881
treatment outcome (815) 815
pharmacology & pharmacy (772) 772
gastroenterology & hepatology (684) 684
amoxicillin - administration & dosage (677) 677
helicobacter pylori - drug effects (581) 581
drug administration schedule (479) 479
clarithromycin - pharmacology (476) 476
omeprazole - administration & dosage (471) 471
clarithromycin - adverse effects (448) 448
microbiology (424) 424
adolescent (412) 412
amoxicillin - therapeutic use (406) 406
anti-ulcer agents - administration & dosage (398) 398
anti-bacterial agents - adverse effects (382) 382
antibiotics (382) 382
anti-bacterial agents - pharmacology (374) 374
animals (357) 357
metronidazole - administration & dosage (338) 338
prospective studies (338) 338
infectious diseases (323) 323
helicobacter infections - microbiology (294) 294
abridged index medicus (287) 287
aged, 80 and over (287) 287
amoxicillin (285) 285
anti-ulcer agents - therapeutic use (285) 285
2-pyridinylmethylsulfinylbenzimidazoles (283) 283
drug therapy (276) 276
omeprazole - analogs & derivatives (268) 268
omeprazole - therapeutic use (267) 267
lansoprazole (264) 264
microbial sensitivity tests (264) 264
administration, oral (259) 259
general & internal medicine (250) 250
time factors (247) 247
health aspects (239) 239
care and treatment (235) 235
helicobacter pylori - isolation & purification (230) 230
double-blind method (226) 226
drug interactions (222) 222
child (221) 221
dosage and administration (218) 218
helicobacter infections (213) 213
medicine, general & internal (213) 213
infections (208) 208
proton pump inhibitors (205) 205
drug resistance, bacterial (204) 204
clarithromycin - pharmacokinetics (199) 199
research (195) 195
metronidazole - therapeutic use (193) 193
young adult (184) 184
helicobacter infections - complications (177) 177
analysis (174) 174
dose-response relationship, drug (172) 172
follow-up studies (171) 171
metronidazole (166) 166
helicobacter infections - diagnosis (165) 165
azithromycin (164) 164
duodenal ulcer - drug therapy (164) 164
proton pump inhibitors - administration & dosage (161) 161
peptic ulcer - drug therapy (160) 160
breath tests (159) 159
drug resistance (159) 159
retrospective studies (152) 152
mice (151) 151
risk factors (149) 149
child, preschool (147) 147
eradication (143) 143
immunology (141) 141
levofloxacin (141) 141
medicine & public health (141) 141
amoxicillin - adverse effects (139) 139
anti-bacterial agents - pharmacokinetics (138) 138
proton pump inhibitors - therapeutic use (135) 135
macrolides (134) 134
penicillins - administration & dosage (134) 134
peptic ulcer - microbiology (128) 128
internal medicine (126) 126
research article (124) 124
gastritis - drug therapy (123) 123
patients (123) 123
clinical trials (122) 122
omeprazole (121) 121
biopsy (119) 119
mycobacterium avium-intracellulare infection - drug therapy (118) 118
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3181) 3181
Japanese (215) 215
Spanish (52) 52
German (51) 51
French (40) 40
Russian (33) 33
Chinese (23) 23
Portuguese (12) 12
Polish (9) 9
Italian (8) 8
Hungarian (6) 6
Korean (5) 5
Danish (4) 4
Turkish (4) 4
Czech (3) 3
Swedish (3) 3
Dutch (2) 2
Norwegian (2) 2
Bulgarian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of internal medicine, ISSN 0953-6205, 07/2016, Volume 32, pp. 84 - 90
Abstract Background Currently only a few studies compare sequential and concomitant non-bismuth Helicobacter pylori therapies referring to high antibiotic... 
Internal Medicine | H. pylori treatment | Sequential treatment | First line | Concomitant treatment | Metronidazole resistance | Clarithromycin resistance | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Esomeprazole - administration & dosage | Humans | Middle Aged | Carbon Isotopes | Drug Resistance, Bacterial | Male | Helicobacter Infections - pathology | Helicobacter pylori | Peptic Ulcer - microbiology | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Female | Helicobacter Infections - metabolism | Urea - metabolism | Amoxicillin - administration & dosage | Drug Therapy, Combination | Dyspepsia - drug therapy | Metronidazole - administration & dosage | Breath Tests | Dyspepsia - microbiology | Pyloric Antrum - pathology | Biopsy | Aged | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Clinical trials | Drug resistance in microorganisms | Clarithromycin | Index Medicus | Helicobacter Infections/drug therapy | Peptic Ulcer/drug therapy | Proton Pump Inhibitors/administration & dosage | Helicobacter Infections/pathology | Peptic Ulcer/microbiology | Tissues and Organs | Life Sciences | Esomeprazole/administration & dosage | Hépatology and Gastroenterology | Pyloric Antrum/pathology | Anti-Bacterial Agents/administration & dosage | Dyspepsia/microbiology | Helicobacter Infections/metabolism | Bacteriology | Clarithromycin/administration & dosage | Urea/metabolism | Metronidazole/administration & dosage | Microbiology and Parasitology | Human health and pathology | Amoxicillin/administration & dosage | Dyspepsia/drug therapy
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 07/2016, Volume 151, Issue 1, pp. 51 - 69.e14
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 09/2013, Volume 76, Issue 3, pp. 455 - 466
.../2J2 , P ‐gp and Bcrp ( ABCG2 ). However, the pharmacokinetic effects and implications of the co‐administration of rivaroxaban and medications that interfere... 
P‐glycoprotein | rivaroxaban | drug interactions | cytochrome P450 | healthy subjects | P-glycoprotein | Rivaroxaban | Healthy subjects | Cytochrome P450 | Drug interactions | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Anticoagulants - administration & dosage | Cytochrome P-450 Enzyme Inhibitors | Erythromycin - pharmacology | Ketoconazole - administration & dosage | Humans | Middle Aged | Cytochrome P-450 Enzyme System - metabolism | Midazolam - administration & dosage | Substrate Specificity | Metabolic Clearance Rate | Thiophenes - administration & dosage | Ketoconazole - pharmacology | Enzyme Inhibitors - administration & dosage | Young Adult | Drug Interactions | Enzyme Inhibitors - pharmacokinetics | Clarithromycin - pharmacokinetics | Clarithromycin - administration & dosage | Adult | Morpholines - administration & dosage | Enzyme Inhibitors - pharmacology | Ketoconazole - pharmacokinetics | Midazolam - pharmacokinetics | Cytochrome P-450 CYP3A - administration & dosage | Erythromycin - administration & dosage | ATP Binding Cassette Transporter, Subfamily B, Member 1 - antagonists & inhibitors | ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism | Thiophenes - pharmacokinetics | Erythromycin - pharmacokinetics | Cytochrome P-450 CYP3A - metabolism | Adolescent | Anticoagulants - pharmacokinetics | Morpholines - pharmacokinetics | Clarithromycin - pharmacology | Midazolam - pharmacology | Ketoconazole | Protease inhibitors | Fluconazole | Proteases | Cytochrome P-450 | Dosage and administration | Anticoagulants (Medicine) | Erythromycin | Thromboembolism | Index Medicus
Journal Article
Gut, ISSN 0017-5749, 09/2016, Volume 65, Issue 9, pp. 1439 - 1446
ObjectiveThe objective of this study was to assess the efficacy, safety and tolerability of vonoprazan, a novel potassium-competitive acid blocker, as a... 
antibiotic therapy | clinical trials | Helicobacter pylori infection | helicobacter pylori - treatment | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Male | Drug Monitoring - methods | Proton Pump Inhibitors - administration & dosage | Pyrroles - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Peptic Ulcer - diagnosis | Pyrroles - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Treatment Outcome | Drug Therapy, Combination - methods | Lansoprazole - adverse effects | Sulfonamides - adverse effects | Amoxicillin - adverse effects | Helicobacter pylori - isolation & purification | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Breath Tests - methods | Peptic Ulcer - etiology | Sulfonamides - administration & dosage | Usage | Safety and security measures | Research | Helicobacter pylori | Antacids | Index Medicus | Abridged Index Medicus | Helicobacter Pylori | HELICOBACTER PYLORI - TREATMENT | CLINICAL TRIALS | 1506 | ANTIBIOTIC THERAPY | HELICOBACTER PYLORI INFECTION
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2016, Volume 388, Issue 10058, pp. 2355 - 2365
Summary Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-day triple therapy for the first-line treatment of Helicobacter... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Proton Pump Inhibitors - administration & dosage | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Organometallic Compounds - therapeutic use | Female | Urea - metabolism | Amoxicillin - administration & dosage | Lansoprazole - administration & dosage | Drug Administration Schedule | Metronidazole - administration & dosage | Breath Tests | Tetracycline - therapeutic use | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Amoxicillin - therapeutic use | Taiwan | Drug Therapy, Combination - statistics & numerical data | Lansoprazole - therapeutic use | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Organometallic Compounds - administration & dosage | Clinical trials | Medical colleges | Helicobacter infections | Care and treatment | Helicobacter pylori | Antiulcer drugs | Analysis | Bacteria | Bacterial infections | Antibiotics | Drug resistance | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2016, Volume 374, Issue 13, pp. 1209 - 1220
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 905 - 913
Journal Article